MA07.11 Survival Outcomes Based on Gender of Advanced Nonsmall Cell Lung Cancer Patients Treated with Pembrolizumab or Nivolumab in Everyday Clinical Practice

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions